Issue 9 2019

12 Acquisition International - Issue 9 2019 Jul19686 One of Australia’s Leading Contract Research Organisations Avance Clinical is an Australian owned Contract Research Organisation, providing quality clinical research to both the local and international drug development industry in the pursuit of a healthier world. Recently, we profiled the company and caught up with Avance Clinical’s CEO, Yvonne Lungershausen to discover more about the services they offer and the talented team which forms the backbone of this award-winning company. ince their inception, Avance Clinical have been offering end- to-end clinical research services across all phases of drug development. Avance Clinical offerings include trial monitoring, local safety reporting, data management, clinical kit services and external auditing to name a few. Today, the company conducts studies across all therapeutic areas, with particular expertise in oncology, dermatology, central nervous system, infectious disease and pain. Although the company has significant experience in late phase studies, Avance Clinical is primarily recognised as an early phase specialist Contract Research Organisation, offering the strongest pharmacokinetic and pharmacodynamic biometric services within their region. As for the clients that the team at Avance Clinical deliver this range of services to, the company have accumulated a global client portfolio, which primarily caters towards small to medium biotechnology companies. Going into further detail, Yvonne begins by informing us more about the company’s diverse client base, as well as how Avance Clinical build these strong connections. “Here at Avance Clinical, our client base currently extends across North America, Canada, New Zealand, Europe and Asia. A large volume of our work comes from repeat business from satisfied customers and referrals. Furthermore, our pipeline of work stems from the strong connections our operational leaders have within the industry. In addition to this, we also have a dedicated business development team operating out of Australia and the United States.” Having established a loyal client base through delivering their award- winning solutions, Avance Clinical dedicate their success to tailoring their services toaddress the client’s clinical development requirements, since they do not believe in a “one size fits all” model. The company is able to adapt to address its clients’ specific requirements maintaining transparency in the delivery of their services. “Our staff become part of our clients’ team” Yvonne emphasises. When discussing the internal culture, Yvonne was keen to highlight the significant role the team play in the overall success of the company. “At Avance Clinical, our staff and culture are key to our success, and without a doubt our staff are our greatest asset. Avance Clinical staff are highly qualified, trained, experienced and dedicated professionals S “This is reflective of our good culture and team stability and lends itself to the high-quality service we provide to our clients.” committed to meeting our client requirements. Many of the Avance Clinical staff have been with the company since its inception. This is reflective of our good culture and team stability and lends itself to the high-quality service we provide to our clients.” As for what the future holds for the company, the team at Avance Clinical hope to further expand the business, their presence and the services they offer to their clients, especially following their recent success in AI’s Global Excellence Awards 2019 where they were righteously awarded the accolade Most Outstanding Full-Service CRO 2019 – Australia. Bringing the interview to a close, Yvonne signs off by revealing what plans lie in the pipeline for the team at Avance Clinical, and where they hope to be in the upcoming years. “Looking ahead, Avance Clinical have plans to expand our footprint in Australia, and through leveraging international collaborative partnerships increase our global presence. Having established ourselves as a leader in early phase trial delivery, we aim to utilise these partnerships to further expand our involvement in later phase clinical trials. Finally, with the continued growth of the pharmaceutical industry in Asia, we are also positioning ourselves to conduct more trials in this region.” Contact: Yvonne Lungershausen Company: Avance Clinical Pty Ltd Address: Level 1, 2 Ann Nelson Drive, 5031, South Australia, Australia Telephone: +61 (0) 417 889 953 Web Address: www.avancecro.com